Showing results (2001-2010 of 3,796) with videos related to

Sort By:
Pageof 380
Oncoimmunology|August 30, 2023
CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cellsXin Jin, Danni Xie, Rui Sun, et al.
Oncoimmunology|August 9, 2023
Histamine antagonists promote cancer immunosurveillancePeng Liu, Guido Kroemer, Oliver Kepp
Oncoimmunology|August 9, 2023
The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1Adeiye A Pilgrim, Hunter C Jonus, Andrew Ho, et al.
Oncoimmunology|August 7, 2023
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancerTatiana V Kudling, James H A Clubb, Santeri Pakola, et al.
Oncoimmunology|August 4, 2023
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cellsMassimo Russo, Nicolò Panini, Paola Fabbrizio, et al.
Oncoimmunology|August 14, 2023
Group 2 innate lymphoid cells boost CD8+ T-cell activation in anti-tumor immune responsesJing Wen, Shipeng Cheng, Ran Wang, et al.
Oncoimmunology|October 20, 2023
A mitochondrial checkpoint to adaptive anticancer immunityOliver Kepp, Peng Liu, Guido Kroemer, et al.
Oncoimmunology|October 20, 2023
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyHayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, et al.
Oncoimmunology|October 25, 2023
CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesisTao Zhang, Ramez Wahib, Dimitra E Zazara, et al.
Oncoimmunology|July 17, 2023
An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelinDaniel Snell, Tea Gunde, Stefan Warmuth, et al.
Pageof 380